Estadísticas de Overexpression of IRS-4 in HER2-amplified breast cancer cells resistant to lapatinib-containing regimens

Visitas totales

views
Overexpression of IRS-4 in HER2-amplified breast cancer cells resistant to lapatinib-containing regimens 0

Visitas totales por mes

views
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0